Role of the fat tissue in the pathogenesis of arterial hypertension and chronic kidney disease

Size: px
Start display at page:

Download "Role of the fat tissue in the pathogenesis of arterial hypertension and chronic kidney disease"

Transcription

1 The 17th Budapest Nephrology School (Nephrology, Hypertension, Dialysis, Transplantation) Under the auspices of ISN, ERA-EDTA and ISP August, 2010 Role of the fat tissue in the pathogenesis of arterial hypertension and chronic kidney disease Prof. Andrzej Więcek (FRCP Edin.) Department of Nephrology, Endocrinology and Metabolic Diseases Medical University of Silesia, Katowice, Poland

2 Obesity the public health problem in Western Countries

3 Obesity Trends Among U.S. Adults Behavioral Risk Factors Surveillance System (BRFSS), 1990, 1998, BMI No Data <10% 10% 14% 15% 19% 20% 24% 25% 29% 30% U.S Obesity Trends , CDC (

4 Obesity and hypertension are two complex disorders that are closely interrelated Larimore J.W. A study of blood pressure in relation to type of bodily habitus. Arch Intern 1923; 31: Faber A. Readings of blood pressure of 1000 healthy individuals age years: An antropometric study. Scand Arch Physiol 1924; 45: Alessandro del Borro (XVII)

5 Hall JE et al.: Braz J Med. Biol Res. 2000; 33, Jones DW et al.: J Hypertens 1994, 12,

6 Hall JE et al.: Braz J Med Biol Res 2000; 33, Hall JE et al.: Hypertension 1994; 22,

7 Hall JE et al.: Braz J Med Biol Res 2000; 33, Hall JE et al.: Hypertension 1994; 22,

8 Hall JE et al.: Braz J Med Biol Res 2000; 33, Hall JE et al.: Hypertension 1994; 22,

9 Effect of obesity to shift renal pressure natriuresis curve to higher arterial pressure Hall J. Curr Opin Nephrol Hypertens, 2003, 12:

10 Hemodynamic, neurohumoral, and renal changes in experimental obesity caused by a high fat diet and in human obesity Hall J. Curr Opin Nephrol Hypertens, :

11 Summary of the mechanisms of obesityinduced hypertension and renal disease Hall J. Curr Opin Nephrol Hypertens 2003,12:

12 * Obestatin (2008) Więcek A. et al. Nephrol. Dial.Transplant. 2007, 22:

13 White adipose tissue in the lean (left) vs. obese (right) state Adipocytes are shown with yellow triglyceride droplets and blue cytoplasm. In the lean state the light blue cytoplasm represent a state of normoxia, whereas the dark blue in the obese state represents a hypoxic state. Pre adipocytes are shown in brown, macrophages in green, blood vessels/endothelial cells in red, and the extracellular matrix as black. Halberg N et al. Endocrinol Metab Clin North Am. 2008; 37: 753

14 Cardiovascular and reologic effects, sleep apnea Renal effects Activation of the sympathetic nervous system Metabolic effects (dyslipidemia, carbohydrate intolerance) Endocrine effects (hyperinsulinism, insulin resistance, hypercortisolism, increased erythropoietin secretion) Increased coagulation/decreased fibrinolysis ( PAI) Haematologic effects NFκB PAI Leptin Adiponectin TNF Angiotensin Resistin Adipocytes Obesity Więcek A. et al., Nephrol. Dial. Transplant. 2002; 17;

15 Cardiovascular-renal actions of leptin Adipose Tissue leptin Heart rate U Na V (chronic effect) U Na V (acute effect) IS NO blood pressure blood pressure Engeli S. et al. Horm Metab Res, 2000; 32; 490

16 Sympathetic nervous system (SNS) and oxidative stress induced nitric oxide (NO) deficiency in the pathogenesis of leptininduced hypertension Bełtowski J., J Hypertension 2006, 24:

17 Cardiovascular and reologic effects, sleep apnea Renal effects Activation of the sympathetic nervous system Metabolic effects (dyslipidemia, carbohydrate intolerance) Endocrine effects (hyperinsulinism, insulin resistance, hypercortisolism, increased erythropoietin secretion) Increased coagulation/decreased fibrinolysis ( PAI) Haematologic effects NFκB PAI Leptin Adiponectin TNF Angiotensin Resistin Adipocytes Obesity Więcek A. et al., Nephrol. Dial. Transplant. 2002; 17;

18 Więcek A. et al. Nephrol. Dial. Transplant. 2007, 22:

19 In patients with essential hypertension (EHP) plasma adiponectin concentration was significantly lower than in normotensive healthy subjects (NHS) 28 Adiponectin [µg/ml] ± ± EHP NHS Adamczak M., Więcek A., Funahashi T., Chudek J., Kokot F., Matsuzawa Y. Am J Hypertens 2003; 16:

20 In patients with essential hypertension blood pressure was inversely related to plasma adiponectin concentration Adamczak M., Więcek A., Funahashi T., Chudek J., Kokot F., Matsuzawa Y. Am J Hypertens 2003; 16:

21 In healthy subjects blood pressure was inversely related to plasma adiponectin concentration Iwashima Y. et al. Hypertension 2004; 43:

22 In obese adolescents 24 hours ambulatory systolic and diastolic blood pressure indices were inversely related to plasma adiponectin concentration adiponectin adiponectin Shatat I.F et al. Ped Res 2009; 65:

23 lipids accumulation in monocyte derived PDGF-BB FGF TNF-α glucose macrophages HB EGF utilization transformation of macrophages into foam cells fatty acid oxidation scavenger receptors Adiponectin insulin signalling superoxide glucose uptake VCAM-1 ICAM-1 E-selectin TIMP NO gluconeogenesis anti-atherogenic actions A. Wiecek, M. Adamczak, J. Chudek: Nephrol Dial Transplant, 2007 insulin-sensitizing actions

24 Potential mechanism of vascular protection by adiponectin Ohashi K., Am J Hypertens, 2010, in press

25 Salt-induced hypertension in adiponectin KO mice Ohashi, K. et al. Hypertension 2006;47:

26 Adiponectin supplementation ameliorates hypertension of genetically obese KKAy mice Ohashi, K. et al. Hypertension 2006;47:

27 Clinical studies showed that: in patients with essential hypertension plasma adiponectin concentration is decreased, high blood pressure values were related to low plasma adiponectin concentration, organ complications of essential hypertension (left ventricular hypertrophy, diastolic left ventricular dysfunction, increased arterial stiffness, increased carotid artery intima-media thicknesses (cimt), occurrence of higher grades of hypertensive retinopathy and albuminuria) were related to low plasma adiponectin concentration.

28 Can hypoadiponectinemia predispose to hypertension? Decreased plasma adiponectin concentration in individuals with increased risk of hypertension: in young normotensive men with a family history of essential hypertension, in young men with high-normal blood pressure (SBP or DBP mmhg), in individuals with prehypertension (SBP or DBP mmhg). Furuhashi M. et al. Hypertens Res 2005; 28: Papadopoulos D.P. et al. Blood Press 2008; 17: Patel D.A. Met Clin Exp 2006; 55: Kazumi T. et al. Diabetes Care 2002; 25: Papadopoulos D.P. et al. J Clin Hypertens (Greenwich) 2005; 7: Bo S. et al. J Hypertens 2009; 27:

29 Decreased plasma adiponectin concentration in young normotensive men with a family history of essential hypertension. Furuhashi M. et al. Hypertens Res 2005: 28:

30 Plasma adiponectin concentrations decreased progressively with higher grades of hypertensive retinopathy Yilmaz M.I. et al. Eur J Endocrinol 2005; 152:

31 Obesity and hypertension pathogenetic factors Endothelial dysfunction Renin-angiotensin-aldosterone system activation Sympathetic nervous system activation Incraesed tubular sodium reabsorption leading to hypervolemia Insulin resistance/diabetes Glomerular hyperfiltration ( afferent arterioles blood flow) Kidney compression due to increased intrabdomen pressure Adipokines metabolism disturbances (among others hyperleptinemia and hipoadiponectinemia)

32 Plasma Adiponectin concentration and mrna expression are decreased in: Obese Diabetes mellitus Hypertension Coronary artery disease Therapy (statins, indapamide) PPRγ activators, ACEi, ARBs, rilmenidine, ribonabant increase adponectin serum concentration and mrna expression

33 Plasma adiponectin concentration before and after indapamide therapy in hypertensive patients Piecha G. et al., Kidney Blood Press. Res. 2007; 30:

34 FCCM = Fet Cell Conditioned Medium Ehrhart-Bornstein M et al.: Proc Natl Acad Sci U S A. 2003; 100:

35 Ehrhart-Bornstein M et al.: Proc Natl Acad Sci U S A. 2003; 100:

36 Ehrhart-Bornstein M et al.: Proc Natl Acad Sci U S A. 2003; 100:

37 Factors involved in the pathogenesis of obesity hypertension Krug A. Hypertension. 2008; 51:

38 Hsu Ch., Ann. Internal Med., 2006; 144: 21-28

39 Prevelence of CKD by BMI categories National Health and Nutrition Examination Survey (n=5897) Kramer H., Contrib. Nephrol., 2006, 151, 1-18

40 Prevelence of CKD (estimated( GFR<60 ml/min/1,73) and microalbumionuria by number of metabolic syndrome triats in the non-diabetic U.S population Kramer H., Contrib. Nephrol., 2006, 151, 1-18

41 Relative risk for graft loss by BMI Srinivals and Meier-Kriesche. Contrib Nephrol, 2006:151

42 Kidney Int. 2008;

43 Relative risk and 95% CI for the assotiaton between obesity and CKD based on cohort studiesin the general populations Wang Y. et al., Kidney Int., 2008;

44 Potential mechanisms of renal injury in patients with obesity and obesity initiated metabolic syndrome Wahba I.M. et al. Clin.. J.Am. Soc. Nephrol., 2007; 2:

45 A role for leptin in Leptin glomerulosclerosis stimulates glomerular endothelial? cell proliferation in vitro and in vivo and transcription and secretion of transforming growth factor b1 (TGFb1), a fibrosis indicating cytokine Leptin administration in rats causes proteinuria and glomerular mesangial matrix expansion Wolf G. et al., Kindey Int. 1999, 56,

46 Development of proteinuria during three weeks of leptin infusion Leptin Control Wolf G. et. al. Kidney Int. 1999, 56,

47 Porreca E. et al.: Am. J. Hypertens., 2002, 15:

48 Leptin and renal fibrosis Wolf and Ziyadeh. Contribution to Nephrology 2006:151

49 Mechanism of kidney injury caused by obesity Thakur V et al. Contrib Nephrol, 2006:151

50 Potential mechanisms of renal dysfunction in obesity and obesity initiated metabolic syndrome Wahba I.M. et al. Clin.. J. Am. Soc. Nephrol., 2007; 2:

51 Albuminuria is related to the decreased plasma adiponectin concentration in patients with essential hypertension and in type 2 DM Tsioufis C. et al. Am J Cardiol. 2005; 96: Barlovic D.P. et al. Cytokine. 2009; 46: Wakabayashi S. et al. Diabetes Care 2004; 27:

52 Negative correlation between albuminuria and plasma adiponectin levels in obese adults African Americans. Sharama K J. Clin. Invest. 118: (2008)

53 Effects of adiponectin on podocytes Ahima R. J. Clin.. Invest. 118: (2008)

54 Ad / mice exhibit increased albuminuria, oxidant stress, and podocyte dysfunction Sharama K J. Clin. Invest. 118: (2008)

55 Adiponectin inhibits permeability across a podocyte monolayer Direct action of adiponectin on podocytes independent of the systemic and/or metabolic effects of adiponectin Sharama K J. Clin.. Invest. 2008, 118:

56 Clinical significance of adipokines in chronic kidney disease Iglesias P et al.: Nephrol Dial Transplant (2010) 25:

57 Thank you for your attention! Katowice

Obesity and the kidney

Obesity and the kidney 22. NATIONAL CONGRESS OF RENAL DISEASES, DIALYSIS & TRANSOPLANATATION NURSING 29. NATIONAL CONGRESS OF NEPHROLOGY, HYPEERTENSION DIALYSIS & TRANSPLANTATION 14-18 November 2012 Obesity and the kidney Prof.

More information

A 2012 update on inflammatory cytokines and adipokines: Revelance for CKD

A 2012 update on inflammatory cytokines and adipokines: Revelance for CKD EURECA-m CME COURSE Cardiovascular Problems and Solutions in Chronic Kidney Disease September 7-8, 2-012, Ankara-Turkey A 2012 update on inflammatory cytokines and adipokines: Revelance for CKD Prof. Andrzej

More information

Metabolic Syndrome, Obesity, Hypertension and Chronic Kidney Disease

Metabolic Syndrome, Obesity, Hypertension and Chronic Kidney Disease The 19th Budapest Nephrology School xyz (Nephrology, Hypertension, Dialysis, Transplantation) 26-31 August 2012 Metabolic Syndrome, Obesity, Hypertension and Chronic Kidney Disease Prof. Andrzej Więcek,

More information

Obesity mediated hypertension and renal dysfunction

Obesity mediated hypertension and renal dysfunction Obesity mediated hypertension and renal dysfunction Gergely Bodor Marion Hervouet Nicky Honnef Mariarosaria Malgadi Julie Robert Tutor: Pr Alina Parvu Objectives 1. Introduction 2. Renal structural and

More information

Prof. Andrzej Wiecek Department of Nephrology, Endocrinology and Metabolic Diseases Medical University of Silesia Katowice, Poland.

Prof. Andrzej Wiecek Department of Nephrology, Endocrinology and Metabolic Diseases Medical University of Silesia Katowice, Poland. What could be the role of renal denervation in chronic kidney disease? Andrzej Wiecek, Katowice, Poland Chairs: Peter J. Blankestijn, Utrecht, The Netherlands Jonathan Moss, Glasgow, UK Prof. Andrzej Wiecek

More information

Obesity and Chronic Kidney. The Catholic University of Korea Cheol Whee Park, M.D.

Obesity and Chronic Kidney. The Catholic University of Korea Cheol Whee Park, M.D. Obesity and Chronic Kidney Disease The Catholic University of Korea Cheol Whee Park, M.D. Epidemic Obesity and type 2 Diabetes in Asia Yoon KH, et al. Lancet 368:1681-1688, 2006 [1 단계 ] 지방세포가커진다 [2 단계

More information

What is New in the Pathogenesis of Salt-sensitive Hypertension?

What is New in the Pathogenesis of Salt-sensitive Hypertension? What is New in the Pathogenesis of Salt-sensitive Hypertension? Prof. Andrzej Wiecek Department of Nephrology, Transplantation and Internal Medicine Medical University of Silesia, Katowice, Poland e-mail:

More information

JOSHUA K. KAYIMA INTERLINKING CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE, AND OBESITY

JOSHUA K. KAYIMA INTERLINKING CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE, AND OBESITY INTERLINKING CARDIOVASCULAR DISEASE, CHRONIC KIDNEY DISEASE, AND OBESITY JOSHUA K. KAYIMA ASSOCIATE PROFESSOR DEPT. OF CLINICAL MEDICINE AND THERAPEUTICS UNIVERSITY OF NAIROBI Introduction According to

More information

Dysglycaemia and Hypertension. Dr E M Manuthu Physician Kitale

Dysglycaemia and Hypertension. Dr E M Manuthu Physician Kitale Dysglycaemia and Hypertension Dr E M Manuthu Physician Kitale None Disclosures DM is MI equivalent MR FIT Objective was to assess predictors of CVD mortality among men with and without diabetes and

More information

ΦΛΕΓΜΟΝΗ ΚΑΙ ΔΙΑΒΗΤΗΣ

ΦΛΕΓΜΟΝΗ ΚΑΙ ΔΙΑΒΗΤΗΣ ΦΛΕΓΜΟΝΗ ΚΑΙ ΔΙΑΒΗΤΗΣ ΘΩΜΑΣ ΠΑΠΑΔΟΠΟΥΛΟΣ, MD, PHD ΕΠΕΜΒΑΤΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ ΙΑΤΡΙΚΟ ΔΙΑΒΑΛΚΑΝΙΚΟ ΚΕΝΤΡΟ Inflammation as a cause of disease has entered the popular imagination. Diet ( macronutrients )

More information

Adipose Tissue as an Endocrine Organ. Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University

Adipose Tissue as an Endocrine Organ. Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University Adipose Tissue as an Endocrine Organ Abdel Moniem Ibrahim, MD Professor of Physiology Cairo University Functions of Adipose Tissue Adipose tissue expresses and secretes a variety of bioactive peptides,

More information

Hypertension is a persistent elevation of B.P. above the normal level. Approximately 1 billion people have hypertension

Hypertension is a persistent elevation of B.P. above the normal level. Approximately 1 billion people have hypertension ISSN: 0975-766X CODEN: IJPTFI Available Online through Research Article www.ijptonline.com STUDY OF LEVEL IN ESSENTIAL HYPERTENSION Krithika Mohanraj 1 *, Dr.R.Rajeswari 2 Bharath University, Chennai.

More information

The Association of Pediatric Obesity with Nocturnal Non-Dipping on. 24-Hour Ambulatory Blood Pressure Monitoring. Ian Macumber.

The Association of Pediatric Obesity with Nocturnal Non-Dipping on. 24-Hour Ambulatory Blood Pressure Monitoring. Ian Macumber. The Association of Pediatric Obesity with Nocturnal Non-Dipping on 24-Hour Ambulatory Blood Pressure Monitoring Ian Macumber A thesis submitted in partial fulfillment of the requirements for the degree

More information

Cardiovascular Protection and the RAS

Cardiovascular Protection and the RAS Cardiovascular Protection and the RAS Katalin Kauser, MD, PhD, DSc Senior Associate Director, Boehringer Ingelheim Pharmaceutical Inc. Micardis Product Pipeline Scientific Support Ridgefield, CT, USA Cardiovascular

More information

Cardiovascular Complications Of Chronic Kidney Disease. Dr Atir Khan Consultant Physician Diabetes & Endocrinology West Wales Hospital, Carmarthen

Cardiovascular Complications Of Chronic Kidney Disease. Dr Atir Khan Consultant Physician Diabetes & Endocrinology West Wales Hospital, Carmarthen Cardiovascular Complications Of Chronic Kidney Disease Dr Atir Khan Consultant Physician Diabetes & Endocrinology West Wales Hospital, Carmarthen Markers of kidney dysfunction Raised Albumin / Creatinine

More information

Metabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine

Metabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine Metabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine Setting the scene GB, 43 yo AA man followed for hypothyroidism returns on LT4 125 mcg/d and has a TSH=1.1

More information

Obesity in the pathogenesis of chronic disease

Obesity in the pathogenesis of chronic disease Portoroz October 16th 2013 Obesity in the pathogenesis of chronic disease Rocco Barazzoni University of Trieste Department of Medical, Surgical and Health Sciences Obesity Trends* Among U.S. Adults BRFSS,

More information

SLOWING PROGRESSION OF KIDNEY DISEASE. Mark Rosenberg MD University of Minnesota

SLOWING PROGRESSION OF KIDNEY DISEASE. Mark Rosenberg MD University of Minnesota SLOWING PROGRESSION OF KIDNEY DISEASE Mark Rosenberg MD University of Minnesota OUTLINE 1. Epidemiology of progression 2. Therapy to slow progression a. Blood Pressure control b. Renin-angiotensin-aldosterone

More information

ARGININE VASOPRESSIN (AVP)

ARGININE VASOPRESSIN (AVP) ARGININE VASOPRESSIN (AVP) AFFECTS BLOOD PRESSURE AND RENAL WATER REABSORPTION WHAT ELSE DOES IT DO? Michael F. Michelis, M.D., F.A.C.P., F.A.S.N. Director, Division of Nephrology Lenox Hill Hospital,

More information

The CARI Guidelines Caring for Australasians with Renal Impairment. ACE Inhibitor and Angiotensin II Antagonist Combination Treatment GUIDELINES

The CARI Guidelines Caring for Australasians with Renal Impairment. ACE Inhibitor and Angiotensin II Antagonist Combination Treatment GUIDELINES ACE Inhibitor and Angiotensin II Antagonist Combination Treatment Date written: September 2004 Final submission: September 2005 Author: Kathy Nicholls GUIDELINES No recommendations possible based on Level

More information

Salt Sensitivity: Mechanisms, Diagnosis, and Clinical Relevance

Salt Sensitivity: Mechanisms, Diagnosis, and Clinical Relevance Salt Sensitivity: Mechanisms, Diagnosis, and Clinical Relevance Matthew R. Weir, MD Professor and Director Division of Nephrology University of Maryland School of Medicine Overview Introduction Mechanisms

More information

3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.

3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H. U.S. Adults: 1988 Nineteen states with 10-14% 14% Prevalence of Obesity (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Metabolic John P. Cello, MD Professor of Medicine and Surgery, University of California,

More information

Cardiovascular Diseases in CKD

Cardiovascular Diseases in CKD 1 Cardiovascular Diseases in CKD Hung-Chun Chen, MD, PhD. Kaohsiung Medical University Taiwan Society of Nephrology 1 2 High Prevalence of CVD in CKD & ESRD Foley RN et al, AJKD 1998; 32(suppl 3):S112-9

More information

Faculty. Disclosures. Learning Objectives. Definitions. Definitions (cont) The Role of the Kidney in Cardiometabolic Disease

Faculty. Disclosures. Learning Objectives. Definitions. Definitions (cont) The Role of the Kidney in Cardiometabolic Disease Faculty The Role of the Kidney in Cardiometabolic Disease Christian W. Mende, MD, FACP, FACN, FASN, FASH Clinical Professor of Medicine University of California at San Diego San Diego, California Disclosures

More information

Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes

Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes Changes and clinical significance of serum vaspin levels in patients with type 2 diabetes L. Yang*, S.J. Chen*, G.Y. Yuan, D. Wang and J.J. Chen Department of Endocrinology, Affiliated Hospital of Jiangsu

More information

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,

More information

Morbidity & Mortality from Chronic Kidney Disease

Morbidity & Mortality from Chronic Kidney Disease Morbidity & Mortality from Chronic Kidney Disease Dr. Lam Man-Fai ( 林萬斐醫生 ) Honorary Clinical Assistant Professor MBBS, MRCP, FHKCP, FHKAM, PDipID (HK), FRCP (Edin, Glasg) Hong Kong Renal Registry Report

More information

SGLT2 inhibition in diabetes: extending from glycaemic control to renal and cardiovascular protection

SGLT2 inhibition in diabetes: extending from glycaemic control to renal and cardiovascular protection SGLT2 inhibition in diabetes: extending from glycaemic control to renal and cardiovascular protection Hiddo Lambers Heerspink Department of Clinical Pharmacy and Pharmacology University Medical Center

More information

Hypertension and diabetic nephropathy

Hypertension and diabetic nephropathy Hypertension and diabetic nephropathy Elisabeth R. Mathiesen Professor, Chief Physician, Dr sci Dep. Of Endocrinology Rigshospitalet, University of Copenhagen Denmark Hypertension Brain Eye Heart Kidney

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Heart Failure Clin 2 (2006) 101 105 Index Note: Page numbers of article titles are in boldface type. A ACE inhibitors, in diabetic hypertension, 30 31 Adipokines, cardiovascular events related to, 6 Advanced

More information

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk

More information

Pongamorn Bunnag, MD Boonsong Ongphiphadhanakul, MD. Mahidol University

Pongamorn Bunnag, MD Boonsong Ongphiphadhanakul, MD. Mahidol University Roles oesof Fetuin-A in Hypertension Pongamorn Bunnag, MD Boonsong Ongphiphadhanakul, MD Ramathibodi Hospital Mahidol University Fetuin-A (Alpha-2-HS-glycoprotein) Multi-functional protein secreted by

More information

Hypertension in Systemic Diseases

Hypertension in Systemic Diseases Hypertension in Systemic Diseases Prof. Andrzej Więcek FRCP (Edin.), FERA Department of Nephrology, Transplantation and Internal Medicine Medical University of Silesia, Katowice, Poland Hypertension in

More information

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE

DISCLOSURES OUTLINE OUTLINE 9/29/2014 ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE ANTI-HYPERTENSIVE MANAGEMENT OF CHRONIC KIDNEY DISEASE DISCLOSURES Editor-in-Chief- Nephrology- UpToDate- (Wolters Klewer) Richard J. Glassock, MD, MACP Geffen School of Medicine at UCLA 1 st Annual Internal

More information

renoprotection therapy goals 208, 209

renoprotection therapy goals 208, 209 Subject Index Aldosterone, plasminogen activator inhibitor-1 induction 163, 164, 168 Aminopeptidases angiotensin II processing 64 66, 214 diabetic expression 214, 215 Angiotensin I intrarenal compartmentalization

More information

1.6 > < ESRD. < >2.0 ESRD Serum creatinine mg/dl

1.6 > < ESRD. < >2.0 ESRD Serum creatinine mg/dl HMG-CoA Reductase Inhibitors and Renal Function Vito M. Campese, MD Professor of Medicine, Physiology and Biophysics Chief, Division of Nephrology and Hypertension Center Keck School of Medicine, USC Los

More information

Metabolic Syndrome and Chronic Kidney Disease

Metabolic Syndrome and Chronic Kidney Disease Metabolic Syndrome and Chronic Kidney Disease Definition of Metabolic Syndrome National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) III Abdominal obesity, defined as a waist circumference

More information

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents

Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of

More information

Fructose, Uric Acid and Hypertension in Children and Adolescents

Fructose, Uric Acid and Hypertension in Children and Adolescents Fructose, Uric Acid and Hypertension in Children and Adolescents Daniel I. Feig, MD, PhD, MS Director, Division of Nephrology Department of Pediatrics University of Alabama, Birmingham Topics for Discussion

More information

Hypertension Management Controversies in the Elderly Patient

Hypertension Management Controversies in the Elderly Patient Hypertension Management Controversies in the Elderly Patient Juan Bowen, MD Geriatric Update for the Primary Care Provider November 17, 2016 2016 MFMER slide-1 Disclosure No financial relationships No

More information

IL METABOLISMO EPATICO DEI CARBOIDRATI IN FISIOLOGIA E PATOLOGIA

IL METABOLISMO EPATICO DEI CARBOIDRATI IN FISIOLOGIA E PATOLOGIA UNIGASTRO Il fegato come centrale metabolica e i fattori di danno oltre ai virus epatitici IL METABOLISMO EPATICO DEI CARBOIDRATI IN FISIOLOGIA E PATOLOGIA Dr Elisabetta Bugianesi Divisione di Gastro-Epatologia

More information

Obesity and Hypertension. Manish Sinha Evelina London Children s Hospital

Obesity and Hypertension. Manish Sinha Evelina London Children s Hospital Obesity and Hypertension Manish Sinha Evelina London Children s Hospital Manchester 30 th June 2017 Scope of Talk Trends of childhood obesity in the UK Prevalence of hypertension in obese children Pathophysiology

More information

Blood Pressure Monitoring in Chronic Kidney Disease

Blood Pressure Monitoring in Chronic Kidney Disease Blood Pressure Monitoring in Chronic Kidney Disease Aldo J. Peixoto, MD FASN FASH Associate Professor of Medicine (Nephrology), YSM Associate Chief of Medicine, VACT Director of Hypertension, VACT American

More information

The role of fetal programming in pathogenesis of arterial hypertension and kidney disease in the adult life

The role of fetal programming in pathogenesis of arterial hypertension and kidney disease in the adult life 22. NATIONAL CONGRESS OF RENAL DISEASES, DIALYSIS & TRANSPLANTATION NURSING 29. NATIONAL CONGRESS OF NEPHROLOGY, HYPERTENSION DIALYSIS & TRANSPLANTATION Antalya, 14-18 November 2012 The role of fetal programming

More information

Blood Pressure Regulation 2. Faisal I. Mohammed, MD,PhD

Blood Pressure Regulation 2. Faisal I. Mohammed, MD,PhD Blood Pressure Regulation 2 Faisal I. Mohammed, MD,PhD 1 Objectives Outline the intermediate term and long term regulators of ABP. Describe the role of Epinephrine, Antidiuretic hormone (ADH), Renin-Angiotensin-Aldosterone

More information

Blood Pressure Regulation 2. Faisal I. Mohammed, MD,PhD

Blood Pressure Regulation 2. Faisal I. Mohammed, MD,PhD Blood Pressure Regulation 2 Faisal I. Mohammed, MD,PhD 1 Objectives Outline the intermediate term and long term regulators of ABP. Describe the role of Epinephrine, Antidiuretic hormone (ADH), Renin-Angiotensin-Aldosterone

More information

Ο ρόλος των τριγλυκεριδίων στην παθογένεια των μικροαγγειοπαθητικών επιπλοκών του σακχαρώδη διαβήτη

Ο ρόλος των τριγλυκεριδίων στην παθογένεια των μικροαγγειοπαθητικών επιπλοκών του σακχαρώδη διαβήτη Ο ρόλος των τριγλυκεριδίων στην παθογένεια των μικροαγγειοπαθητικών επιπλοκών του σακχαρώδη διαβήτη Κωνσταντίνος Τζιόμαλος Επίκουρος Καθηγητής Παθολογίας Α Προπαιδευτική Παθολογική Κλινική, Νοσοκομείο

More information

Metabolic Consequences of Anti Hypertensives: Is It Clinically Important?

Metabolic Consequences of Anti Hypertensives: Is It Clinically Important? Metabolic Consequences of Anti Hypertensives: Is It Clinically Important?,FACA,FICA,MASH,FVBWG,MISCP CONSULTANT OF CARDIOLOGY DIRECTOR OF PORT-FOUAD HOSPITAL CCU Consideration of antihypertensive agents

More information

Jared Moore, MD, FACP

Jared Moore, MD, FACP Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner

More information

The role of physical activity in the prevention and management of hypertension and obesity

The role of physical activity in the prevention and management of hypertension and obesity The 1 st World Congress on Controversies in Obesity, Diabetes and Hypertension (CODHy) Berlin, October 26-29 2005 The role of physical activity in the prevention and management of hypertension and obesity

More information

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy

Hypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy Hypertension Update Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy Introduction 1/3 of US adults have HTN More prevalent in non-hispanic

More information

HSN301 REVISION NOTES TOPIC 1 METABOLIC SYNDROME

HSN301 REVISION NOTES TOPIC 1 METABOLIC SYNDROME HSN301 REVISION NOTES TOPIC 1 METABOLIC SYNDROME What does the term Metabolic Syndrome describe? Metabolic syndrome describes a cluster of cardio-metabolic conditions that increase one's risk of developing

More information

Effects of Exercise and Physical Activity on Diabetes Mellitus and Obesity

Effects of Exercise and Physical Activity on Diabetes Mellitus and Obesity 1 EXERCISE IS MEDICINE: The Science Behind the Movement Effects of Exercise and Physical Activity on Diabetes Mellitus and Obesity Rosa Allyn G. Sy, MD, FPCP, FPSEDM Endocrinology, Diabetes, Metabolism

More information

Diabetes and Concomitant Cardiovascular Disease: Guideline Recommendations and Future Directions

Diabetes and Concomitant Cardiovascular Disease: Guideline Recommendations and Future Directions Diabetes and Concomitant Cardiovascular Disease: Guideline Recommendations and Future Directions Diabetes is one of the largest global health emergencies of 21 st century, with the number of people with

More information

The Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk

The Metabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk Update 2013 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes Anschutz Health and Wellness Center University of Colorado School of Medicine Denver Health

More information

The organs of the human body were created to perform ten functions among which is the function of the kidney to furnish the human being with thought.

The organs of the human body were created to perform ten functions among which is the function of the kidney to furnish the human being with thought. The organs of the human body were created to perform ten functions among which is the function of the kidney to furnish the human being with thought. Leviticus Rabba 3 Talmud Berochoth 6 1 b Outline &

More information

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria

1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria 1. Albuminuria an early sign of glomerular damage and renal disease albuminuria Cardio-renal continuum REGRESS Target organ damage Asymptomatic CKD New risk factors Atherosclerosis Target organ damage

More information

hypertension Head of prevention and control of CVD disease office Ministry of heath

hypertension Head of prevention and control of CVD disease office Ministry of heath hypertension t. Samavat MD,Cadiologist,MPH Head of prevention and control of CVD disease office Ministry of heath RECOMMENDATIONS FOR HYPERTENSION DIAGNOSIS, ASSESSMENT, AND TREATMENT Definition of hypertension

More information

Estrogens vs Testosterone for cardiovascular health and longevity

Estrogens vs Testosterone for cardiovascular health and longevity Estrogens vs Testosterone for cardiovascular health and longevity Panagiota Pietri, MD, PhD, FESC Director of Hypertension Unit Athens Medical Center Athens, Greece Women vs Men Is there a difference in

More information

Pathology of Hypertension

Pathology of Hypertension 2016-03-07 Pathology of Hypertension Honghe Zhang honghezhang@zju.edu.cn Tel:88208199 Department of Pathology ❶ Genetic predisposition ❷ Dietary factors ❸ Environmental factors ❹ Others Definition and

More information

신장환자의혈압조절 나기영. Factors involved in the regulation of blood pressure

신장환자의혈압조절 나기영. Factors involved in the regulation of blood pressure 신장환자의혈압조절 K/DOQI Clinical practice guidelines on Hypertension and Antihypertensive agents in CKD 나기영 Factors involved in the regulation of blood pressure Renal function curve MAP (mmhg) Central role of

More information

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015

Objectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents

More information

Hypertension: What s new since JNC 7. Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF

Hypertension: What s new since JNC 7. Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF Hypertension: What s new since JNC 7 Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF Disclosures Spectral Diagnostics Site investigator Eli Lilly Site investigator ACP IM ITE writing committee NBME Step

More information

Diabetic Nephropathy

Diabetic Nephropathy Diabetic Nephropathy Objectives: Know what Diabetic Nephropathy means. Know how common is Diabetic nephropathy in Saudi Arabia and to appreciate how bad are this complications. Know the risk factors of

More information

New Antihypertensive Strategies to Improve Blood Pressure Control

New Antihypertensive Strategies to Improve Blood Pressure Control New Antihypertensive Strategies to Improve Blood Pressure Control Antonio Coca, MD, PhD,, FRCP, FESC Hypertension and Vascular Risk Unit Department of Internal Medicine. Hospital Clínic (IDIBAPS) University

More information

An update on the obesity epidemics in CKD and in ESRD. Does it really matter?

An update on the obesity epidemics in CKD and in ESRD. Does it really matter? EURECA-m 2011 An update on cutting-edge Cardiovascular and Renal Medicine themes. An update on the obesity epidemics in CKD and in ESRD. Does it really matter? Francesca Mallamaci BMI>30 25 Ireland 20

More information

Hypertension and Diabetes. Edward Shahady MD Medical Director Diabetes Master Clinician Program Florida Academy of Family Physicians

Hypertension and Diabetes. Edward Shahady MD Medical Director Diabetes Master Clinician Program Florida Academy of Family Physicians Hypertension and Diabetes Edward Shahady MD Medical Director Diabetes Master Clinician Program Florida Academy of Family Physicians Objectives Describe the prevalence of hypertension and hypertension control

More information

Cedars Sinai Diabetes. Michael A. Weber

Cedars Sinai Diabetes. Michael A. Weber Cedars Sinai Diabetes Michael A. Weber Speaker Disclosures I disclose that I am a Consultant for: Ablative Solutions, Boston Scientific, Boehringer Ingelheim, Eli Lilly, Forest, Medtronics, Novartis, ReCor

More information

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine

Management of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Management of Hypertension M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Disturbing Trends in Hypertension HTN awareness, treatment and control rates are decreasing

More information

TIP. Documentation and coding guide. Disease definitions* Prevalence and statistics associated with HTN**

TIP. Documentation and coding guide. Disease definitions* Prevalence and statistics associated with HTN** Documentation and coding guide Disease definitions* HTN is diagnosed when the average of two or more (systolic of diastolic) blood pressure readings are found to be elevated on two or more office visits

More information

In The Name Of God. In The Name Of. EMRI Modeling Group

In The Name Of God. In The Name Of. EMRI Modeling Group In The Name Of God In The Name Of God EMRI Modeling Group Cells work together in functionally related groups called tissues Types of tissues: Epithelial lining and covering Connective support Muscle movement

More information

Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin

Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin Diabetic Kidney Disease Tripti Singh MD Department of Nephrology University of Wisconsin Disclosures I have no financial relationship with the manufacturers of any commercial product discussed during this

More information

Managing patients with renal disease

Managing patients with renal disease Managing patients with renal disease Hiddo Lambers Heerspink, MD University Medical Centre Groningen, The Netherlands Asian Cardio Diabetes Forum April 23 24, 216 Kuala Lumpur, Malaysia Prevalent cases,

More information

Objectives. Kidney Complications With Diabetes. Case 10/21/2015

Objectives. Kidney Complications With Diabetes. Case 10/21/2015 Objectives Kidney Complications With Diabetes Brian Boerner, MD Diabetes, Endocrinology, and Metabolism University of Nebraska Medical Center Review screening for, and management of, albuminuria Review

More information

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI

More information

Diabetes and kidney disease.

Diabetes and kidney disease. Diabetes and kidney disease. What are the implications? Can it be prevented? Nice 18 june 2010 Lars G Weiss. M.D. Ph.D. Department of Neprology Central Hospital Karlstad Sweden Diabetic nephropathy vs

More information

Guest Speaker Evaluations Viewer Call-In Thanks to our Sponsors: Phone: Fax: Public Health Live T 2 B 2

Guest Speaker Evaluations Viewer Call-In Thanks to our Sponsors: Phone: Fax: Public Health Live T 2 B 2 Public Health Live T 2 B 2 Chronic Kidney Disease in Diabetes: Early Identification and Intervention Guest Speaker Joseph Vassalotti, MD, FASN Chief Medical Officer National Kidney Foundation Thanks to

More information

Prof. Armando Torres Nephrology Section Hospital Universitario de Canarias University of La Laguna Tenerife, Canary Islands, Spain.

Prof. Armando Torres Nephrology Section Hospital Universitario de Canarias University of La Laguna Tenerife, Canary Islands, Spain. Does RAS blockade improve outcomes after kidney transplantation? Armando Torres, La Laguna, Spain Chairs: Hans De Fijter, Leiden, The Netherlands Armando Torres, La Laguna, Spain Prof. Armando Torres Nephrology

More information

Role of angiotensin II in the progression of diabetic nephropathy therapeutic implications

Role of angiotensin II in the progression of diabetic nephropathy therapeutic implications Nephrol Dial Transplant (2003) 18 [Suppl 5]: v16 v20 DOI: 10.1093/ndt/gfg1036 Role of angiotensin II in the progression of diabetic nephropathy therapeutic implications Andrzej Wie cek, Jerzy Chudek and

More information

Optimal blood pressure targets in chronic kidney disease

Optimal blood pressure targets in chronic kidney disease Optimal blood pressure targets in chronic kidney disease Pr. Michel Burnier Service of Nephrology and Hypertension University Hospital Lausanne Switzerland Evidence-Based Guideline for the Management

More information

Circulation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output.

Circulation. Blood Pressure and Antihypertensive Medications. Venous Return. Arterial flow. Regulation of Cardiac Output. Circulation Blood Pressure and Antihypertensive Medications Two systems Pulmonary (low pressure) Systemic (high pressure) Aorta 120 mmhg Large arteries 110 mmhg Arterioles 40 mmhg Arteriolar capillaries

More information

When should you treat blood pressure in the young?

When should you treat blood pressure in the young? ESC Stockholm - Dilemmas in Cardiovascular Disease Prevention in the Young: 30 th August 2010 When should you treat blood pressure in the young? Bryan Williams MD FRCP FAHA FESC Professor of Medicine Department

More information

Setting the standard

Setting the standard SCLEROSTIN in NEPHROLOGY MOST REFERENCED OPTIMIZED FOR CLINICAL SAMPLES Setting the standard for clinical research. SCLEROSTIN A BONE-RELATED PROTEIN URINE PROTOCOL AVAILABLE Sclerostin ELISA - Assay Characteristics

More information

ALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR)

ALLHAT RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) 1 RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 4 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) 6 / 5 / 1006-1 2 Introduction Hypertension is the second most common cause of end-stage

More information

Dr. Mehmet Kanbay Department of Medicine Division of Nephrology Istanbul Medeniyet University School of Medicine Istanbul, Turkey.

Dr. Mehmet Kanbay Department of Medicine Division of Nephrology Istanbul Medeniyet University School of Medicine Istanbul, Turkey. The uric acid dilemma: causal risk factor for hypertension and CKD or mere bystander? Mehmet Kanbay, Istanbul, Turkey Chairs: Anton H. van den Meiracker, Rotterdam, The Netherlands Claudia R.C. Van Roeyen,

More information

FOCUS ON CARDIOVASCULAR DISEASE

FOCUS ON CARDIOVASCULAR DISEASE The Consequences of Vitamin D Deficiency: FOCUS ON CARDIOVASCULAR DISEASE Vitamin D deficiency is a global health problem. With all the medical advances of the century, vitamin D deficiency is still epidemic.

More information

Association Between Hypertension and Coronary Artery Disease as Assessed by Coronary Computed Tomography

Association Between Hypertension and Coronary Artery Disease as Assessed by Coronary Computed Tomography Original Paper Association Between Hypertension and Coronary Artery Disease as Assessed by Coronary Computed Tomography Ryoko Mitsutake, MD, PhD; Shin-ichiro Miura, MD, PhD; Yuhei Shiga, MD; Yoshinari

More information

ACEIs / ARBs NDHP dihydropyridine ( DHP ) ACEIs ARBs ACEIs ARBs NDHP. ( GFR ) 60 ml/min/1.73m ( chronic kidney disease, CKD )

ACEIs / ARBs NDHP dihydropyridine ( DHP ) ACEIs ARBs ACEIs ARBs NDHP. ( GFR ) 60 ml/min/1.73m ( chronic kidney disease, CKD ) 005 16 175-180 1 1 ( chronic kidney disease, CKD ) 003 ( end-stage renal disease, ESRD ) Angiotensin-converting enzyme inhibitors ( ) angiotensin receptor blockers ( ) nondihydropyridine ( NDHP ) / NDHP

More information

Uric acid and CKD. Sunil Badve Conjoint Associate Professor, UNSW Staff Specialist, St George

Uric acid and CKD. Sunil Badve Conjoint Associate Professor, UNSW Staff Specialist, St George Uric acid and CKD Sunil Badve Conjoint Associate Professor, UNSW Staff Specialist, St George Hospital @Badves Case Mr J, 52 Male, referred in June 2015 DM type 2 (4 years), HTN, diabetic retinopathy, diabetic

More information

Metabolic syndrome, obesity, diabetes, and theier implications

Metabolic syndrome, obesity, diabetes, and theier implications Metabolic syndrome, obesity, diabetes, and theier implications jan.krtil@lf1.cuni.cz Institute of Medical Biochemistry and Laboratory Diagnostics &1 st Department of Medicine Diabetes mellitus type 2 (T2DM)

More information

902 Biomed Environ Sci, 2014; 27(11):

902 Biomed Environ Sci, 2014; 27(11): 902 Biomed Environ Sci, 2014; 27(11): 902-906 Letter to the Editor Curcuminoids Target Decreasing Serum Adipocyte-fatty Acid Binding Protein Levels in Their Glucose-lowering Effect in Patients with Type

More information

Long-term study of the association of adipokines and glucose variability with diabetic complications

Long-term study of the association of adipokines and glucose variability with diabetic complications ORIGINAL ARTICLE Korean J Intern Med 2018;33:367-382 Long-term study of the association of adipokines and glucose variability with diabetic complications Jin Joo Cha, Hye Sook Min, Kitae Kim, Mi Jin Lee,

More information

Impact of Adiponectin on Left Ventricular Mass Index in Non-complicated Obese Subjects

Impact of Adiponectin on Left Ventricular Mass Index in Non-complicated Obese Subjects Endocrine Journal 2008, 55 (3), 523 528 Impact of Adiponectin on Left Ventricular Mass Index in Non-complicated Obese Subjects HAKSUN EBİNÇ, FATMA AYERDEN EBİNÇ*, ZÜBEYDE NUR ÖZKURT**, MEHMET TOLGA DOĞRU,

More information

Diabetic Nephropathy 2009

Diabetic Nephropathy 2009 Diabetic Nephropathy 2009 Michael T McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Diabetic Nephropathy Clinical Stages Hyperfunction

More information

Hypertension Update Background

Hypertension Update Background Hypertension Update Background Overview Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Management Guideline Comparison

More information

Ipovitaminosi D e metabolismo calcio-fosforo in dialisi peritoneale. Maurizio Gallieni Università degli Studi di Milano

Ipovitaminosi D e metabolismo calcio-fosforo in dialisi peritoneale. Maurizio Gallieni Università degli Studi di Milano Ipovitaminosi D e metabolismo calcio-fosforo in dialisi peritoneale Maurizio Gallieni Università degli Studi di Milano G Ital Nefrol 2018 - ISSN 1724-5990 Nutrients 2017, 9, 328 Vitamin D deficiency (

More information

Prevalence of anemia and cardiovascular diseases in chronic kidney disease patients: a single tertiary care centre study

Prevalence of anemia and cardiovascular diseases in chronic kidney disease patients: a single tertiary care centre study International Journal of Advances in Medicine Sathyan S et al. Int J Adv Med. 2017 Feb;4(1):247-251 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20170120

More information

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center

Cardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Cardiovascular Disease in CKD Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Objectives Describe prevalence for cardiovascular disease in CKD

More information

Roadmap. Diabetes and the Metabolic Syndrome in the Asian Population. Asian. subgroups 8.9. in U.S. (% of total

Roadmap. Diabetes and the Metabolic Syndrome in the Asian Population. Asian. subgroups 8.9. in U.S. (% of total Diabetes and the Metabolic Syndrome in the Asian Population Alka Kanaya, MD Associate Professor of Medicine, UCSF Feb 26, 2010 Roadmap 1. Diabetes in Asian Americans Prevalence in the U.S. Risk factors

More information

NAM JUNE PAIK: Rhapsody in Video

NAM JUNE PAIK: Rhapsody in Video NAM JUNE PAIK: Rhapsody in Video 혈관연구회추계학회 2007.10.13 Renin-angiotensin-aldosterone System Kwang Kon Koh, MD, FACC, FAHA Cardiology Gachon University Gil Medical Center Incheon, Korea Cytokines oxldl Ang

More information